微导管在肝脏良性实体肿瘤介入治疗中的临床应用  

Clinicalapplication of Microcatheter in the Interventional Treatment of Benign Solid Tumor of Liver

作　　者：胡文军[1] 翟健坤[1] 曹彭钢[1] 

机构地区：[1]东莞市太平人民医院介入科,广东东莞523905

出　　处：《罕少疾病杂志》2012年第1期17-19,共3页Journal of Rare and Uncommon Diseases

摘　　要：目的探讨SP微导管在肝脏良性实体肿瘤介入治疗中的临床应用。方法 42例肝脏良性实体肿瘤行超选择性肝动脉插管并经微导管内注射平阳霉素碘油乳剂(PLE),瘤体大的可用明胶海绵颗粒追加栓塞。随访6-24个月,观察肝脏良性实体肿瘤栓塞前、后肿瘤大小、异常血管湖变化、临床症状和并发症发生情况。结果 42例肝脏良性肿瘤患者栓塞术后瘤体缩小约45%-70%,部分可缩小约90%,异常血管湖消失,总有效率100%,无与手术有关的严重并发症发生。结论 PLE经SP微导管注入行超选择性肝动脉栓塞治疗肝脏良性实体肿瘤是非常安全和有效的方法。Objective To investigate the clinical efficiency of SP microcatheter in the treatment of benign solid tumor of liver.Methods Forty two patients with benign solid tumor of liver were embolized by transmicrocatheter superselective intra hepatic arterial infusion of PLE.The abnormal vascular lakes of large tumor were treated with gelfoam particles additionally.All patients were followed up for 6 to 24 months.The changes of tumor size and abnormal vascular lakes were measured and compared before and after the embolization.The relative clinical symptoms and complications were observed.Results In all cases,the tumor size significantly decreased 45%～70%,even partly decreased 90% after PLE embolization and abnormal vascular lakes disappeared.The clinical symptoms were significantly released.Total effective rate was 100%.No severe complication happened.Conclusion Transmicrocatheter superselective hepatic arterial embolization with PLE is an effective and safe therapy for benign solid tumor of liver.

关 键 词：SP微导管 肝脏良性实体肿瘤 介入栓塞术 平阳霉素碘油乳剂 

分 类 号：R735.7[医药卫生—肿瘤]